Pretreatment determination of TPMT – state of the art in clinical practice A. TemlE. SchaeffelerM. Schwab Editorial 07 February 2009 Pages: 219 - 221
Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus R. AntonucciL. CuzzolinV. Fanos Clinical Trial 02 December 2008 Pages: 223 - 230
The effects of problem-based learning integration in a course on rational drug use: a comparative study between two Croatian medical schools Robert LikicDinko VitezicIgor Francetic Special Article 16 December 2008 Pages: 231 - 237
Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem Yixi WangChangxi WangMin Huang Pharmacogenetics 21 October 2008 Pages: 239 - 247
Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients Hua-Wen XinHui XiongAi-Rong Yu Pharmacogenetics 02 December 2008 Pages: 249 - 255
Distribution of TPMT risk alleles for thioupurine toxicity in the Israeli population Edna EfratiLior AdlerEli Sprecher Pharmacogenetics 02 December 2008 Pages: 257 - 262
Voriconazole drastically increases exposure to oral oxycodone Nora M. HagelbergTuija H. NieminenKlaus T. Olkkola Pharmacokinetics and Disposition 03 October 2008 Pages: 263 - 271
The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery Stuart A. McCluskeyWing K. CheungKeyvan Karkouti Pharmacokinetics and Disposition 30 October 2008 Pages: 273 - 279
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers Guo WangHe-Ping LeiHong-Hao Zhou Pharmacokinetics and Disposition 04 November 2008 Pages: 281 - 285
St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive Liane Will-ShahabSteffen BauerAxel Brattström Pharmacokinetics and Disposition Open access 18 November 2008 Pages: 287 - 294
Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors Anne M. HauskenKari FuruJørgen G. Bramness Pharmacoepidemiology and Prescription 23 September 2008 Pages: 295 - 301
Drug use in pregnancy—physicians’ evaluation of quality and clinical impact of drug information centres Sofia Kristina Frost WidnesJan Schjøtt Pharmacoepidemiology and Prescription 04 December 2008 Pages: 303 - 308
Persistence of antimuscarinic drug use Søren BrostrømJesper Hallas Pharmacoepidemiology and Prescription 24 December 2008 Pages: 309 - 314
An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results Ola P. HoleSigurd Nitter-HaugeFinn Ø. Winther Debate Article 23 December 2008 Pages: 315 - 318
Cytochrome P450 2C19 genetic polymorphisms in Ugandans Jun MiuraCelestino ObuaTomonori Tateishi Letter to the Editors 11 November 2008 Pages: 319 - 320
Hyperthermic intraperitoneal perfusion chemotherapy—views on the observed variability in oxaliplatin pharmacokinetics Nuggehally R. Srinivas Letter to the Editors 15 November 2008 Pages: 321 - 322
Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine Jun KatoTakehiko MoriShinichiro Okamoto Letter to the Editors 25 November 2008 Pages: 323 - 324